Study Shows Alarming Rise in Heart Failure Deaths, Especially Among Younger Adults
After decades of decline, heart failure mortality is climbing, with a dramatic rise in heart failure deaths among adults age 45 and younger.
Stay updated with breaking news from Javed Butler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After decades of decline, heart failure mortality is climbing, with a dramatic rise in heart failure deaths among adults age 45 and younger.
The HCPLive Endocrinology month in review for April 2024 spotlights SURMOUNT-OSA, STEP HFpEF DM, new ACP guidelines for T2D, and more!
No reduction in risk for first hospitalization for heart failure or death seen among patients at increased risk for heart failure
No reduction in risk for first hospitalization for heart failure or death seen among patients at increased risk for heart failure
Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session.